This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Jun;43(6):1348-9.

doi: 10.1097/CCM.0000000000001030.

Targeting sirtuin to modulate human inflammation

Anthony F Suffredini¹

Affiliations

PMID: 25978168
DOI: 10.1097/CCM.0000000000001030

Editorial

Targeting sirtuin to modulate human inflammation

Anthony F Suffredini. Crit Care Med. 2015 Jun.

. 2015 Jun;43(6):1348-9.

doi: 10.1097/CCM.0000000000001030.

Author

Anthony F Suffredini¹

Affiliation

¹ Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

PMID: 25978168
DOI: 10.1097/CCM.0000000000001030

No abstract available

PubMed Disclaimer

Comment on

The Selective Sirtuin 1 Activator SRT2104 Reduces Endotoxin-Induced Cytokine Release and Coagulation Activation in Humans.
van der Meer AJ, Scicluna BP, Moerland PD, Lin J, Jacobson EW, Vlasuk GP, van der Poll T. van der Meer AJ, et al. Crit Care Med. 2015 Jun;43(6):e199-202. doi: 10.1097/CCM.0000000000000949. Crit Care Med. 2015. PMID: 25978169 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer